Literature DB >> 15328377

Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450.

Lin Wu1, Jun Gu, Huadong Cui, Qing-Yu Zhang, Melissa Behr, Cheng Fang, Yan Weng, Kerri Kluetzman, Pamela J Swiatek, Weizhu Yang, Laurence Kaminsky, Xinxin Ding.   

Abstract

A mouse model with a hypomorphic NADPH-cytochrome P450 reductase (Cpr) gene (designated Cpr(low) allele) was generated and characterized in this study. The Cpr gene in these mice was disrupted by the insertion of a neo gene in intron 15, which led to 74 to 95% decreases in CPR expression in all tissues examined, including olfactory mucosa, adrenal gland, brain, testis, ovary, lung, kidney, liver, and heart. In the liver, a pattern of pericentral distribution of CPR protein was preserved in the Cpr(low/low) mice, despite an overall reduction in CPR expression. Genotype distribution in F2 pups indicated limited embryonic lethality associated with the Cpr(low) allele, a finding that confirms the role of CPR-dependent enzymes in development. Adult male homozygotes had decreased body weight and decreased heart, lung, and kidney weights, whereas homozygous Cpr(low) females, which had increased serum testosterone and progesterone and decreased copulatory activities, were infertile. Furthermore, adult Cpr(low/low) mice had decreased plasma cholesterol, and some mice developed mild centrilobular hepatic lipidosis. In addition, despite apparently compensatory increases in total microsomal cytochrome P450 content in the liver and kidney, the decreases in CPR expression were accompanied by reductions in systemic clearance of pentobarbital, as well as in hepatic microsomal metabolism of acetaminophen and testosterone. These phenotypes illustrate the potential impact of a globally decreased CPR activity in human adults, and this novel knock-in mouse model provides a unique opportunity for further explorations of the in vivo roles of CPR and CPR-dependent enzymes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328377     DOI: 10.1124/jpet.104.073353

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  25 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  mRNA distribution and heterologous expression of orphan cytochrome P450 20A1.

Authors:  Katarina Stark; Zhong-Liu Wu; Cheryl J Bartleson; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2008-06-09       Impact factor: 3.922

3.  Atropselective Disposition of 2,2',3,4',6-Pentachlorobiphenyl (PCB 91) and Identification of Its Metabolites in Mice with Liver-Specific Deletion of Cytochrome P450 Reductase.

Authors:  Xianai Wu; Guangshu Zhai; Jerald L Schnoor; Hans-Joachim Lehmler
Journal:  Chem Res Toxicol       Date:  2019-08-26       Impact factor: 3.739

4.  Proximal Tubular Vacuolization and Hypersensitivity to Drug-Induced Nephrotoxicity in Male Mice With Decreased Expression of the NADPH-Cytochrome P450 Reductase.

Authors:  Liang Ding; Lei Li; Senyan Liu; Xiaochen Bao; Kathleen G Dickman; Stewart S Sell; Changlin Mei; Qing-Yu Zhang; Jun Gu; Xinxin Ding
Journal:  Toxicol Sci       Date:  2020-02-01       Impact factor: 4.849

5.  Analysis of testosterone and dihydrotestosterone in mouse tissues by liquid chromatography-electrospray ionization-tandem mass spectrometry.

Authors:  Yan Weng; Fang Xie; Li Xu; Dmitri Zagorevski; David C Spink; Xinxin Ding
Journal:  Anal Biochem       Date:  2010-03-31       Impact factor: 3.365

6.  Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.

Authors:  Ningwu Huang; Amit V Pandey; Vishal Agrawal; William Reardon; Pablo D Lapunzina; David Mowat; Ethylin Wang Jabs; Guy Van Vliet; Joseph Sack; Christa E Flück; Walter L Miller
Journal:  Am J Hum Genet       Date:  2005-03-25       Impact factor: 11.025

7.  Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population.

Authors:  Huijie Li; Suyun Li; Qiang Wang; Chongqi Jia
Journal:  Hum Genet       Date:  2016-09-22       Impact factor: 4.132

8.  An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine.

Authors:  Qing-Yu Zhang; Cheng Fang; Jin Zhang; Deborah Dunbar; Laurence Kaminsky; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2008-12-04       Impact factor: 3.922

9.  Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model.

Authors:  Yuan Wei; Lei Li; Xin Zhou; Qing-Yu Zhang; Anwar Dunbar; Fang Liu; Kerri Kluetzman; Weizhu Yang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2012-10-16       Impact factor: 3.922

10.  Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice.

Authors:  Jun Yao; Cheng-gang Li; Li-kun Gong; Chen-chen Feng; Chun-zhu Li; Man Gao; Yang Luan; Xin-ming Qi; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.